FACDX | VGHCX | FACDX / VGHCX | |
Total Expense Ratio | 0.93 | 0.37 | 251% |
Annual Report Gross Expense Ratio | 0.93 | 0.37 | 251% |
Fund Existence | 29 years | 41 years | - |
Gain YTD | 1.367 | -0.225 | -608% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.27B | 35.4B | 9% |
Annual Yield % from dividends | 0.00 | 0.87 | - |
Returns for 1 year | -15.97 | -21.80 | 73% |
Returns for 3 years | 1.75 | -7.68 | -23% |
Returns for 5 years | -6.30 | -15.61 | 40% |
Returns for 10 years | 36.05 | -19.80 | -182% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 70.31 | 1.02 | +1.48% |
Virtus LifeSci Biotech Products ETF | |||
AVSE | 61.20 | 0.84 | +1.39% |
Avantis Responsible Emerging Mkts Eq ETF | |||
BKLN | 20.94 | 0.01 | +0.05% |
Invesco Senior Loan ETF | |||
PBMY | 29.22 | N/A | N/A |
PGIM S&P 500 Buffer 20 ETF - May | |||
USSG | 59.07 | -0.46 | -0.78% |
Xtrackers MSCI USA Selection Eq ETF |